Security Snapshot

Humacyte, Inc. - Common Stock (HUMA) Institutional Ownership

CUSIP: 44486Q103

13F Institutional Holders and Ownership History from Q3 2021 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

100

Shares (Excl. Options)

42.56MFull value: 42,563,901 · shares · 30 Sep 2026

Price

$0.52

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-9,081,412
Value change
-$7,523,392
Number of holders
100
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
272,828,667
SEC-reported price per share
$0.45
Insider filing price
$0.45
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • HUMA - Humacyte, Inc. - Common Stock is tracked under CUSIP 44486Q103.
  • 100 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 165 to 100 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $57.35MFull value: $57,347,177 · USD · 30 Jun 2026
    to
    $22.03MFull value: $22,033,640 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 100 institutions filings for Q3 2026.

Open SEC evidence

Security key

44486Q103

13F reference period

Q3 2026

13F holders

100

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
HUMA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 4.7% $16,367,453 12,787,073 Davidson Kempner Capital Management LP 12 Jun 2026
BlackRock, Inc. 1.5% $3,193,732 4,092,430 BlackRock, Inc. 30 Jun 2026
As of 30 Sep 2026, 100 institutional investors reported holding
42.56MFull value: 42,563,901 · shares · 30 Sep 2026
shares of Humacyte, Inc. - Common Stock (HUMA). This represents 16% of the company’s total
272.83MFull value: 272,828,667 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
15%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 4% 10,964,108 0% $5,679,408
ANTIPODES PARTNERS Ltd 3% 8,258,350 0.08% $4,275,348
GREAT POINT PARTNERS LLC 1.4% 3,750,000 0.51% $1,941,375
MARSHALL WACE, LLP 1.1% 2,996,553 0% $1,558,208
GEODE CAPITAL MANAGEMENT, LLC 0.98% 2,676,475 0% $1,386,080
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.61% 1,670,302 0% $864,715
VANGUARD FIDUCIARY TRUST CO 0.59% 1,599,496 0% $828,539
Private Advisor Group, LLC 0.35% 947,765 0% $490,662
LPL Financial LLC 0.34% 938,041 0% $485,624
WEALTH EFFECTS LLC 0.34% 919,720 0.13% $476,139
STATE STREET CORP 0.33% 900,646 0% $466,264
VANGUARD PORTFOLIO MANAGEMENT LLC 0.28% 767,569 0% $397,601
Lion Point Capital, LP 0.24% 650,000 1.9% $336,505
Woodline Partners LP 0.18% 500,582 0% $259,151
Invesco Ltd. 0.16% 448,633 0% $232,257
GSA CAPITAL PARTNERS LLP 0.12% 334,510 0.01% $173,000
LJI Wealth Management, LLC 0.09% 252,500 0.02% $130,719
GOLDMAN SACHS GROUP INC 0.09% 242,915 0% $125,757
United Asset Strategies, Inc. 0.08% 209,608 0.01% $108,514
Hudson Bay Capital Management LP 0.07% 195,000 0% $100,952
Catalyst Funds Management Pty Ltd 0.06% 162,119 0.01% $83,929
Empowered Funds, LLC 0.06% 157,378 0% $81,475
Creative Planning 0.05% 149,129 0% $77,204
GROUP ONE TRADING LLC 0.05% 136,595 0% $70,715
BOLTON SECURITIES CORPORATION 0.04% 120,000 0% $62,124

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
21
Headline period
Q3 2026
Rows shown
1-21 of 21
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 42,563,901 $22,033,640 -$7,523,392 $0.52 100
2026 Q2 73,507,445 $57,347,177 +$11,100,636 $0.78 165
2026 Q1 58,879,310 $35,736,274 +$739,029 $0.61 157
2025 Q4 55,385,756 $53,205,316 +$7,815,206 $0.96 146
2025 Q3 45,803,224 $79,706,858 -$20,549,961 $1.74 138
2025 Q2 56,964,566 $119,040,607 -$1,729,485 $2.09 155
2025 Q1 60,715,449 $103,532,553 +$24,167,009 $1.70 162
2024 Q4 42,106,165 $212,715,890 +$30,515,138 $5.05 161
2024 Q3 35,792,230 $194,660,626 +$23,757,191 $5.44 143
2024 Q2 31,200,014 $149,783,918 +$47,689,218 $4.80 120
2024 Q1 23,275,197 $72,382,833 +$17,071,734 $3.11 95
2023 Q4 17,820,871 $50,656,070 +$3,312,296 $2.84 87
2023 Q3 16,610,977 $48,671,458 +$5,715,520 $2.93 83
2023 Q2 14,729,897 $42,225,781 +$7,517,496 $2.86 75
2023 Q1 12,062,725 $37,417,372 +$154,698 $3.09 68
2022 Q4 11,918,522 $25,143,027 -$3,006,763 $2.11 71
2022 Q3 11,840,854 $38,602,556 -$5,136,200 $3.26 68
2022 Q2 13,437,579 $43,130,190 +$8,049,232 $3.21 75
2022 Q1 10,487,756 $73,993,016 +$6,152,869 $7.06 69
2021 Q4 9,522,696 $69,016,600 +$7,310,797 $7.25 58
2021 Q3 4,907,194 $56,957,000 +$56,946,000 $11.61 31
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .